Editorial: Revisiting the challenges and opportunities in cancer drug resistance.
作者信息
Dakal Tikam Chand, Sharma Narendra Kumar, Sharma Amit
机构信息
Genome and Computational Biology Lab, Department of Biotechnology, Mohanlal Sukhadia University, Udaipur, Rajasthan, India.
Department of Bioscience and Biotechnology, Banasthali Vidyapith, Tonk, Rajasthan, India.
出版信息
Front Mol Biosci. 2024 Sep 30;11:1497754. doi: 10.3389/fmolb.2024.1497754. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Revisiting the challenges and opportunities in cancer drug resistance.社论：重新审视癌症耐药性中的挑战与机遇
Front Mol Biosci. 2024 Sep 30;11:1497754. doi: 10.3389/fmolb.2024.1497754. eCollection 2024.
2
Editorial: Revisiting Cross-Cultural Comparison on International Business: Challenges and Opportunities.社论：重新审视国际商务中的跨文化比较：挑战与机遇
Front Psychol. 2022 Jun 13;13:941217. doi: 10.3389/fpsyg.2022.941217. eCollection 2022.
3
Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.药物不良反应背景下的药物基因组学与全球精准医学：未来十年的十大机遇与挑战
OMICS. 2016 Oct;20(10):593-603. doi: 10.1089/omi.2016.0122. Epub 2016 Sep 19.
4
Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.癌症患者来源的基于细胞的模型：功能精准医学中的应用与挑战
Life (Basel). 2024 Sep 10;14(9):1142. doi: 10.3390/life14091142.
5
Deep learning of pharmacogenomics resources: moving towards precision oncology.基于药理学基因组学资源的深度学习：迈向精准肿瘤学。
Brief Bioinform. 2020 Dec 1;21(6):2066-2083. doi: 10.1093/bib/bbz144.
6
Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine.重新审视卵巢癌的化疗耐药性：机制、生物标志物与精准医学。
Genes Dis. 2020 Dec 1;9(3):668-681. doi: 10.1016/j.gendis.2020.11.017. eCollection 2022 May.
7
Application of liquid biopsy in precision medicine: opportunities and challenges.液体活检在精准医学中的应用：机遇与挑战。
Front Med. 2017 Dec;11(4):522-527. doi: 10.1007/s11684-017-0526-7. Epub 2017 Jul 25.
8
Application of precision medicine in clinical routine in haematology-Challenges and opportunities.精准医学在血液学临床常规中的应用——挑战与机遇。
J Intern Med. 2022 Aug;292(2):243-261. doi: 10.1111/joim.13508. Epub 2022 Jun 4.
9
Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in : Challenges and Opportunities.社论：应对[具体领域]中耐药性、药物发现和疫苗开发的方法：挑战与机遇
Front Microbiol. 2022 Apr 29;13:871464. doi: 10.3389/fmicb.2022.871464. eCollection 2022.
10
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance.精准肿瘤学为靶向 KRAS 抑制剂耐药提供了机会。
Trends Cancer. 2023 Jan;9(1):42-54. doi: 10.1016/j.trecan.2022.10.001. Epub 2022 Oct 28.
引用本文的文献
1
Redefining Chemoresistance: Natural Bioactives as Molecular Modulators at the Cancer-Tumor Microenvironment Interface.重新定义化疗耐药性：天然生物活性物质作为癌症-肿瘤微环境界面的分子调节剂
Int J Mol Sci. 2025 Aug 20;26(16):8037. doi: 10.3390/ijms26168037.
2
Precise Electromagnetic Modulation of the Cell Cycle and Its Applications in Cancer Therapy.细胞周期的精确电磁调制及其在癌症治疗中的应用。
Int J Mol Sci. 2025 May 7;26(9):4445. doi: 10.3390/ijms26094445.
本文引用的文献
1
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective.耐药性癌症中的组蛋白修饰：从癌症干细胞和免疫逃逸的角度来看。
Exp Mol Med. 2023 Jul;55(7):1333-1347. doi: 10.1038/s12276-023-01014-z. Epub 2023 Jul 3.
2
Mechanisms of Multidrug Resistance in Cancer Chemotherapy.癌症化疗中的多药耐药机制。
Int J Mol Sci. 2020 May 2;21(9):3233. doi: 10.3390/ijms21093233.
3
Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment.癌细胞的肿瘤内异质性及其对癌症治疗的影响。
Acta Pharmacol Sin. 2015 Oct;36(10):1219-27. doi: 10.1038/aps.2015.92. Epub 2015 Sep 21.
Zotero 插件